The Centre for Clinical Haematology (CCH) at the Queen Elizabeth Hospital Birmingham will be leading the way in administering trials of the revolutionary cancer treatment highlighted in the national media today.
The Independent reported:
“A revolutionary cancer therapy that uses the body’s own immune cells to attack metastatic tumours that have spread is being hailed as a “paradigm shift” in treatment of the disease.
Patients with advanced blood cancers who were not expected to live beyond five months have shown complete remission after 18 months of follow-up checks with no signs of the disease returning, scientists have revealed.”
Blood cancer charity Cure Leukaemia helps finance the CCH to fund life-saving and world first clinical trials to treat patients with blood cancer who have exhausted standard treatment options. Cure Leukaemia co-founder Professor Charlie Craddock CBE said:
“I think this advance is exciting and real and represents a new and important treatment breakthrough for the many patients with blood cancers for whom current drug and transplant therapies fail to deliver long term survival.
The UK should be proud that much of the brilliant science underpinning this advance comes from its own scientific teams. The CCH at Birmingham, with a number of major London centres, has been identified in the first wave of UK centres to trial these therapies.
A substantial expansion of our clinical trials resource will be required to assess these exciting new treatment options so that we ensure patients benefit as rapidly as possible from this exciting new technology.”
Cure Leukaemia’s funding is essential for the delivery of these revolutionary treatments as the charity funds the specialist research nurses to ensure patients are constantly monitored and cared for. Without the specialist research nurses these vital clinical trials would not run and patients would miss the opportunity to access these potentially life-saving therapies.
To make a donation to Cure Leukaemia and ensure patients continue to receive these clinical therapies click HERE
Cure Leukaemia's £1m Centre Appeal 2017